Darwin Wealth Management LLC Buys Shares of 603 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Darwin Wealth Management LLC purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 603 shares of the medical equipment provider’s stock, valued at approximately $203,000.

Other institutional investors have also recently made changes to their positions in the company. OFI Invest Asset Management bought a new stake in Intuitive Surgical during the 3rd quarter valued at approximately $25,000. Baystate Wealth Management LLC lifted its stake in Intuitive Surgical by 150.0% in the 4th quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 45 shares in the last quarter. MCF Advisors LLC boosted its holdings in shares of Intuitive Surgical by 108.1% during the 4th quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock valued at $26,000 after purchasing an additional 40 shares during the last quarter. Headinvest LLC purchased a new position in shares of Intuitive Surgical during the third quarter valued at about $28,000. Finally, Stone House Investment Management LLC increased its holdings in shares of Intuitive Surgical by 100.0% in the third quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 50 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 196 shares of the business’s stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $400.00, for a total value of $78,400.00. Following the completion of the transaction, the senior vice president now directly owns 1,842 shares of the company’s stock, valued at $736,800. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, SVP Mark Brosius sold 196 shares of the firm’s stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $400.00, for a total transaction of $78,400.00. Following the sale, the senior vice president now directly owns 1,842 shares in the company, valued at approximately $736,800. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Mark J. Rubash sold 1,709 shares of the stock in a transaction that occurred on Friday, May 3rd. The stock was sold at an average price of $380.00, for a total value of $649,420.00. Following the transaction, the director now owns 16,051 shares in the company, valued at approximately $6,099,380. The disclosure for this sale can be found here. Insiders sold 147,927 shares of company stock worth $57,064,459 over the last three months. Company insiders own 0.80% of the company’s stock.

Intuitive Surgical Stock Performance

NASDAQ:ISRG traded up $5.08 during trading hours on Thursday, reaching $385.45. The company’s stock had a trading volume of 882,172 shares, compared to its average volume of 1,594,653. The company has a market capitalization of $136.72 billion, a P/E ratio of 69.58, a price-to-earnings-growth ratio of 4.93 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $403.76. The stock has a 50 day moving average price of $385.21 and a two-hundred day moving average price of $352.17.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The firm had revenue of $1.89 billion during the quarter, compared to analysts’ expectations of $1.87 billion. During the same period last year, the business posted $1.00 earnings per share. The company’s revenue for the quarter was up 11.5% compared to the same quarter last year. As a group, analysts predict that Intuitive Surgical, Inc. will post 4.8 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have issued reports on ISRG shares. Stifel Nicolaus lifted their price objective on Intuitive Surgical from $420.00 to $430.00 and gave the stock a “buy” rating in a research note on Monday, April 8th. Piper Sandler boosted their target price on shares of Intuitive Surgical from $425.00 to $435.00 and gave the stock an “overweight” rating in a report on Friday, April 19th. Jefferies Financial Group lifted their price target on Intuitive Surgical from $365.00 to $375.00 and gave the stock a “hold” rating in a research report on Friday, April 19th. BTIG Research boosted their target price on Intuitive Surgical from $412.00 to $421.00 and gave the company a “buy” rating in a research report on Friday, April 19th. Finally, StockNews.com cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating in a research report on Thursday, February 29th. Five equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat, Intuitive Surgical presently has an average rating of “Moderate Buy” and an average target price of $396.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.